Company Overview and News
9MFY18 Highlights • Consolidated revenue of Rs.15.6 billion, an increase of 12.4% YoY • PAT amounted to Rs. 1.6 billion, up 23.0% YoY, due to strong Agri and Consumer Goods sector results • Healthcare revenue up 3.3% YoY to Rs. 6.0 billion • Strong growth in Consumer Goods, revenue up 27.4% YoY to Rs 3.8 billion • Agri revenue grew 13.3% YoY to Rs 5.4 billion • EPS grew 63.8% YoY to Rs 5.29
Tata Global Beverages (TGBL) has sold its stake in joint venture firm Estate Management Services Private Limited (EMSPL) for a consideration of Rs 120 crore.
Tata Global Beverages (TGBL) has sold its stake in joint venture firm Estate Management Services Private Limited (EMSPL) for a consideration of ₹120 crore.
Nov 30, 2017 (LBO) – Sri Lanka’s Planters Association has called for more support for palm oil as profits from the crop are rising at a healthy pace.
June 30, 2017 (LBO) – Sri Lanka’s Watawala Plantations is planning to set up a separate company relating to the tea business segment of the company by segregating its operational assets and liabilities.
Diversified Conglomerate concludes 1st Quarter on a high with 30% Profit growth, boosted by turnaround in Agribusiness
Aug 04, 2016 (LBO) – India’s High Commissioner in Sri Lanka Y. K. Sinha says that the first round of negotiations on the Indo-Sri Lanka Economic and Technology Cooperation Framework Agreement (ETCA) will start shortly.
Watawala Tea Ceylon inks exclusive partnership with Shangri La, Asia’s leading luxury hotel group, regarded as one of the world’s finest hospitality players Watawala Tea Ceylon, a Sunshine Holdings Group company, announced its partnership with Shangri-La Hotels and Resorts to launch its premium brand – ‘Zesta Connoisseur’ teas – at 90 plus luxury properties of the hotel chain across 24 countries.
Diversified conglomerate Sunshine Holdings PLC’s subs idiary Watawala Plantations PLC yesterday entered into a joint venture with Singapore-based asset manager Duxton Asset Management to set up a US$ 11.5 million dairy operation in Lonach Estate in Watawala. “Today we have signed a joint venture of approximately US$ 11.5 million for a dairy farm in Lonach Estate in Watawala Plantations” Sunshine Holdings Managing Director Vish Gowindasamy said.
Mar 24, 2016 (LBO) – Sri Lanka’s Watawala Plantations, one of the largest tea plantation companies in the island has entered into a Joint Venture Agreement with PADC Holdings in Cayman to set up a new dairy farm.
Nepal’s only billionaire Binod Chaudhary’s CG Group launched the ambitious Zinc Journey brand in Sri Lanka yesterday in partnership with several local leading hospitality companies.
Jan 27, 2016 (LBO) - Sri Lanka's Watawala Plantations PLC reported net profit of 439 million rupees for the nine months to 31 December 2015, up seven percent, on profits from palm oil and lower out...
By Vijaya Kumar – Special correspondents and bigwigs in the planation industry keep hammering at us that plantation workers in Sri Lankan are vastly overpaid, any increases in pay will be spent on liquor, no increase in pay is possible unless tied to productivity and that workers should agree to a new system where...
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...